Entering text into the input field will update the search result below

BioPharmX Corporation beats on revenue

  • BioPharmX Corporation (BPMX): Q2 GAAP EPS of -$0.02.
  • Revenue of $0.02M (flat Y/Y) beats by $0.01M.
  • Cash and equivalents of $6.58M.
  • Press Release

Recommended For You

About TMBRQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TMBRQ--
Timber Pharmaceuticals, Inc.